Jakavi 15 mg Tablets also known as Jakafi (generic name : ruxolitinib) is a prescription drug manufactured by Novartis. These Jakavi 15 mg Tablets are known for treating disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis. Jakavi 15 mg Tablets are available in tablet form in the pack size of 56 tablets (4 strips of 14 tablets). These tablets are available in dosage of is 5 mg, 15 mg and 20 mg.
Side Effects : Patients may suffer debilitating symptoms including fever, extreme fatigue, intractable pruritus (itchiness), night sweats, weight loss, bone or muscle pain, poor quality of life and shortened survival.